Genomic Technologies Lab
As technologies for genomic science continue to advance and diversify, it is essential to stay at the cutting-edge. New technologies allow us to explore new areas of biology, and enhance understanding and diagnosis of human disease.
The Genomic Technologies Lab aims to: develop, adopt, optimise and validate new technologies and methods that may shed new light on the genome; show how these can be used to address unsolved challenges in genomic medicine; and facilitate their translation into clinical practice.
Our recent work on long-read sequencing – harnessing the latest technologies from Oxford Nanopore and Pacific Biosciences – showcases our end-to-end tech research program, spanning from computational methods development to large-scale genomic analysis of diverse cohorts in health and disease. This program can be summarised in five themes:
- Development and adoption of new genomic technologies
- Software/hardware engineering for sophisticated, efficient, scalable analysis of genomics data
- Application of new technologies to diverse human cohorts to understand genetic diversity
- Application of new technologies to address unsolved diagnostic challenges
- Clinical translation of new genomic technologies
Our innovative and highly collaborative approach is important to maintaining Garvan’s position as an international leader in technology and genomics research.